Humana · Hydroxychloroquine · US health-plan appeal rights

Hydroxychloroquine denied as not medically necessary by Humana?

Q: How long do I have to appeal a Humana Hydroxychloroquine denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

Most insurers reverse a medical-necessity denial when the appeal cites the specific clinical guideline (NCCN, ADA, AACE, etc.) that supports the requested treatment for your indication.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-09

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What Humana typically requires

SLE meeting EULAR/ACR 2019 criteria. Maximum dose ≤5 mg/kg actual body weight/day per AAO 2016/2025. Baseline ophthalmology exam within 1 yr of initiation. Annual screening after 5 yr (or earlier if risk factors: renal disease, tamoxifen, cumulative dose >1000 g) with SD-OCT + 10-2 HVF (24-2 if Asian ancestry per AAO 2025).

Source policy: Humana Coverage Policy: Hydroxychloroquine (Plaquenil) for SLE with AAO Retinal Screening Compliance

What works in the appeal

AAO 2016 Marmor Ophthalmology + AAO 2025 revision set ≤5 mg/kg actual weight ceiling; risk of retinopathy <1% at 5 yr, <2% at 10 yr, ~20% only after 20 yr cumulative. Submit current SD-OCT + 10-2 HVF (24-2 in Asian patients due to extramacular pattern). EULAR 2023 + KDIGO 2024 + ACR all endorse HCQ for ALL SLE unless absolute contraindication — denying HCQ accelerates flare risk, organ damage accrual, and mortality (HCQ improves 10-yr survival per Ruiz-Irastorza Lupus 2006). Chloroquine has HIGHER ocular toxicity per AAO and is NOT a safer substitute. If suspected retinopathy, dose-reduction or discontinuation is appropriate, not switch to chloroquine.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other Humana appeals

Other denial reasons for Humana Hydroxychloroquine

denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational denied as not FDA-approved for this use

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-09. Editorial standards: denialhelp.com/authors.